chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt like bee sting or sunburn; red, not like a fire red but reddened; warmer to touch than rest of skin; itching; reaction on skin around injection site,small at that time and is slowly getting bigger,4 inches by 2.5 inches; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (felt like bee sting or sunburn), ERYTHEMA (red, not like a fire red but reddened), FEELING HOT (warmer to touch than rest of skin), PRURITUS (itching) and INJECTION SITE REACTION (reaction on skin around injection site,small at that time and is slowly getting bigger,4 inches by 2.5 inches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder, Swelling of legs, Depression, Metabolic syndrome, Acid reflux (oesophageal) and Spinal stenosis. Concurrent medical conditions included Hypertension, Cholesterol and Bee sting hypersensitivity. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), ATORVASTATIN for Cholesterol, SERTRALINE for Depression, METOPROLOL SUCCINATE (TOPROL XL) for Hypertension, METFORMIN for Metabolic syndrome, GABAPENTIN for Pain, IBUPROFEN for Spinal stenosis, BUMETANIDE (BUMEX) for Swelling of legs, LEVOTHYROXINE for Thyroid disorder, HYDROCHLOROTHIAZIDE (THIAZIDE), ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM CARBONATE, ERGOCALCIFEROL (CALCIUM AND VITAMIN D), GLUCOSAMINE and COLECALCIFEROL, UBIDECARENONE (CO-Q10+VITAMIN D3) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced RASH ERYTHEMATOUS (felt like bee sting or sunburn), ERYTHEMA (red, not like a fire red but reddened), FEELING HOT (warmer to touch than rest of skin), PRURITUS (itching) and INJECTION SITE REACTION (reaction on skin around injection site,small at that time and is slowly getting bigger,4 inches by 2.5 inches). At the time of the report, RASH ERYTHEMATOUS (felt like bee sting or sunburn), ERYTHEMA (red, not like a fire red but reddened), FEELING HOT (warmer to touch than rest of skin), PRURITUS (itching) and INJECTION SITE REACTION (reaction on skin around injection site,small at that time and is slowly getting bigger,4 inches by 2.5 inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided
After about 12 hours from receiving the booster shot, I started to feel a lot of soreness, muscle aches throughout my body, severe chills, and started feeling nauseous. Ibuprofen did not help. In the middle of the night, I went to go throw up in the toilet, started to feel very dizzy, my blood pressure dropped, and I passed out, causing me to hit my head on the toilet and hurt my face. Husband found me and called an ambulance to bring me to the ER. While getting checked by paramedics before being loaded up in the ambulance, I again had another episode of nausea, dizziness, and low blood pressure (feeling like I was going to pass out again).
Pt. came in day after vaccine with redness, pain and warm injection site. Recommended ice, pain reliever and ZYRTEC. She is to contact primary for further instructions. Dr. was also faxed.
Appeared on day 9 - red patch on upper left arm, 2 1/2" x 1" approximately, irregular in shape (hourglass but bottom half more pronounced), hot to touch, itchy, knot/inflammation behind it. Not really bothersome just noticeable (particularly when lying on that side). Took Benadryl and Tylenol as recommended.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed vaccine and advised lot 007B21A maintained activity needed to protect against covid 19 the day vaccine was administered.  Also patient did not call in to complain  with any adverse event.  This is administrative error without adverse event.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Seizure-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Visual Changes/Disturbances-Medium
Information has been received from a healthcare worker referring to 17 unspecified patients of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with doses of improperly stored (Merck) VARIVAX (strength, lot#, dose and route were not reported) (incorrect product storage). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax 29MAR96 & 1APR96 pt exp a facial rash;the following day pt devel about 10 lesions, which progressed to about 50 lesions w/in a few days;no further details were provided;
Information has been received from a nurse, for the Pregnancy Registry for GARDASIL, concerning a 16 year old female who on 31-MAY-2007 was vaccinated with her first dose of GARDASIL (route and lot# not provided).  On 31-JUL-2007 the patient was vaccinated with her second dose of GARDASIL (route and lot# not provided).  On 09-NOV-2007 the patient was vaccinated with her third dose of GARDASIL (route and lot# not provided).  Subsequently, it was reported that the patient had a sonogram (date unspecified) and was pregnant (Gestation 6.5 months, LMP 03-SEP-2007).  Follow up information received stated that on 18-FEB-2008 that patient was diagnosed with a bacterial urine infection and was treated with MACROBID 1 tablet, PO, BID for 7 days.  The outcome of the bacterial UTI  was not reported.  On 09-MAY-2008 at 38 6/7 weeks gestation the patient gave birth to a male infant 6 pounds 7.7 oz., 19.3 inches, the babies Apgar score was reported as 1.  It was reported that the baby was born with an unspecified infection which was treated with unspecified antibiotics.  It was reported that the baby "had a hard time breathing and stayed in the hospital for 1 week".  Additional information regarding the prolonged hospitalization of the baby was not provided.  Additional information has been requested.
After receiving vaccines, patient developed progressively worsening erythema/ pain in legs, especially right leg and fever, culminating in a temp 104 and visit to doctor where she was diagnosed with cellulitis and treated with Keflex.
She began to feel ill and went to the bathroom. I heard her talking to herself about being ill, then I heard a thump. She had fallen off the toilet and was complaining of feeling very ill. She was incoherent for apx 4 min. She then passed out and had a seizure for about 30 sec. She then came to and asked to lie down. I called 911 but she said she wanted to lie down. She is now sleeping.
Information has been received from a physician concerning a 71 year old female who on 14-DEC-2006 was vaccinated with a dose of Pneumovax 23 (Lot #651328/1046P).  Concomitant therapy given on the same day included a dose of influenza virus vaccine (unspecified).  On 14-DEC-2006, the patient developed irritation and swelling around the site of injection.  Unspecified medical attention was sought.  No laboratory studies were performed.  At the time of this report, the patient was recovering.  No product quality complaint was involved.  Additional information has been requested.
muscle aches; fever; backache; extremely sore arm; Excruciating headache that lasted to 12 to 15 hours; chills; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of MYALGIA (muscle aches), PYREXIA (fever), BACK PAIN (backache), PAIN IN EXTREMITY (extremely sore arm) and HEADACHE (Excruciating headache that lasted to 12 to 15 hours) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was given by the reporter.  Concomitant products included SPIRONOLACTONE and PIROXICAM (PAXIL [PIROXICAM]) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle aches), PYREXIA (fever), BACK PAIN (backache), PAIN IN EXTREMITY (extremely sore arm), HEADACHE (Excruciating headache that lasted to 12 to 15 hours) and CHILLS (chills). At the time of the report, MYALGIA (muscle aches), PYREXIA (fever), BACK PAIN (backache), PAIN IN EXTREMITY (extremely sore arm), HEADACHE (Excruciating headache that lasted to 12 to 15 hours) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Treatment information was not provided.    This case was linked to INC.-MOD-2021-118621 (E2B Linked Report).; Sender's Comments: INC.-MOD-2021-118621:1st Dose.
About 10 days after getting shot  - severe urticaria - throat and lungs closed up - could not breathe well -  Started with Facial swelling  - urgent care 2x - 1 round of prednisone - seeing allergist - hot skin - take 4 zyrtec daily now and 2 pepcid  -  has been present 7 weeks now - no signs of stopping - the medication works but 1 missed dose and it is back to square one
This is a spontaneous report from a contactable nurse via Pfizer sales representative. A 20-year-old female patient received TRUMENBA;(lot number and expiration date not reported) via an unspecified route of administration, on an unspecified date, 0.5 ml single; and HPV vaccine via an unspecified route of administration, on an unspecified date, at unspecified dose and frequency both given for immunization. Relevant medical history and concomitant medications were not reported. On an unknown date, the patient complained of burning and pain at the injection site after receiving meningococcal group b rlp2086. Patient also received HPV vaccine in the same arm during visit. Patient may have received other vaccines in the opposite arm during the visit as well. Outcome of the event was unknown. Information on the batch number has been requested.
patient who received an expired dose of PNEUMOVAX23; no other issues or concerned noted; This spontaneous report has been received from a nurse regarding a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (dose, frequency and route of administration were not reported; lot # S034299, expiration date 01-JUL-2021). The reported wanted to know if the patient should be revaccinated. No other issues or concern were noted. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: S034299; expirationdate: 01-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
chills; body aches; diarrhea; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 20Apr2021, this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent. A 16 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "chills"; PAIN (non-serious), outcome "unknown", described as "body aches"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea". Therapeutic measures were taken as a result of diarrhoea.  Additional Information: The patient took bismuth subsalicylate (PEPTO BISMOL) to treat the diarrhea and the reporter wanted to know if that will affect the Pfizer-BioNTech Covid-19 Vaccine. The reporter also wanted to know diarrhea was a common reaction to the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cluster of pustular,  typical H. Zoster lesions over left scapula.  causing itching and local pain. Treated within 24 hours with Valcyclovir 1 gm every 8 hours for 7 days. Lesions gradually resolved over the next seven days.
1 day after vaccine - fever, chills, fatigue. Swelling (L) arm - not at injection site. Headache, decreased appetite.
I was diagnose with COVID. I had exhaustion, runny nose, fever and painful skin.; I was diagnose with COVID. I had exhaustion, runny nose, fever and painful skin.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Jan2021 as dose 1, single (Batch/Lot number: unknown) at the age of 28 years, in left arm, on 31Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 28 years, in left arm and on 31Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 29 years, in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "known allergy to berries" (unspecified if ongoing). There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient has no history of COVID-19 prior vaccination.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Apr2022, outcome "recovered" (Apr2022) and all described as "I was diagnose with COVID. I had exhaustion, runny nose, fever and painful skin.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Apr2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vaccinations given 4/26. Redness and swelling the same day.   Evaluated 4/27, circle drawn around area and treated with BENADRYL.  Returned 4/28 with increasing redness and swelling and treated for cellulitis (tx: KEFLEX & BENADRYL).
i got the flu; Initial information was received on 18-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and gender patient who stated got the flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (unknown formulation) (lot number, expiry date, strength, frequency was unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient had a non-serious event i got the flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Husband told me he was going to pass out within a few minutes of receiving the shot, I called for the pharmacy tech to come help me before he fell off of the chair.  They called for EMS to come and check him out, his bp was 118 over 78.  He is home now feeling tired . We can follow up with his doctor if her is not feeling better.
Patient was given the ADACEL on 03/08/19 and came back to the pharamcy on 03/21/2019 complaining of left shoulder pain. He was having pain when he was lifting his left arm laterally. I recomended that he get in contact with his Dr right away to have it looked at.
Significant swelling and erythema at the injection site both proximal thighs worse on Lt thigh. No fever measured area of swelling and erythema Lt 4 inches Rt 2 inches.
PAIN IN TEETH; RIGHT BREAST SORENESS; MILD GENERALIZED ACHING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On 11-MAR-2021, the subject experienced pain in teeth. On 11-MAR-2021, the subject experienced right breast soreness. On 11-MAR-2021, the subject experienced mild generalized aching. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain in teeth on 18-MAR-2021, and right breast soreness on 17-MAR-2021, and was recovering from mild generalized aching. This report was non-serious.
"felt weird for a day" patient could not describe the feeling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("felt weird for a day" patient could not describe the feeling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event and Root canal procedure (two).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced FEELING ABNORMAL ("felt weird for a day" patient could not describe the feeling). On 20-Mar-2021, FEELING ABNORMAL ("felt weird for a day" patient could not describe the feeling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided Patient was called to ask if there is any report of tooth side effects due to the vaccine because  he has to have two root canals
24 hours, post vax, pt brought in with 8-10cm of erythema and hyperemia to right thigh. Pt to use Benadryl and ice.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 4:40 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021 at 4:40 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.  It was reported that the vaccine was at frozen storage condition at the time of the temperature excursion. Excursion duration was 1 month.  On 19-Nov-2021, the Moderna COVID-19 vaccine vial went from the super cold freezer to the refrigerator. The vaccine was returned to the freezer/refrigerator/ultra cold freezer, or maintained at room temperature.  No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursion issues had happened.  The patient was given doses from a vial that were stored in an ultracold freezer which is colder than they should have been.   This case was linked to MOD-2021-402935 (Patient Link).
Patient received a second booster shot on 12/14/2021. Patient received original booster on 11/3/2021. Spoke to patient's primary care physician, and patient has not reported any adverse effects from additional dose.
Since getting the 1st vaccine, I have gotten headaches every single day. Some are mild and then some are severe, turning into migraines where I cannot get out of bed. I have taken Tylenol, Advil and Excederin for them. Sometimes the medication works and other days it does not.
sore throat; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history were reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitants medication were provided. No treatment medication were provided. No lab data has been provided by the reporter.
Injection site (upper left arm) extremely painful. Pain in area has persisted in arm and shoulder, limiting range of motion and movement.